Furthermore, in breast cancer cell lines (MDA-MB-231 cells), miR-7 and miR-218 resulted in an increase of cells at the G1 phase and a decrease of cells at the S phase with reactivation of CLDN6 by means of epigenetic switches in DNA methylation and histone modification [46]. This evidence concerns the gene CLDN6 and breast cancer.